Relationship between expression of CD40-CD40 ligand system and serum cholesterol levels in patients with hypercholesterolemia

Chinese Medical Journal

Volumn 117, Issue 7, 2004, Pages 1101-1103

  Yan, Jin Chuan ^a   Wu, Zong Gui ^a   Li, Li ^a   Zhong, Ren Qian ^a   Kong, Xian Tao ^a  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Atherosclerosis; CD40; CD40L; Hypercholesterolemia

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; SIMVASTATIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESIVENESS;

ADULT; ANTIGENS, CD40; BLOOD PLATELETS; CD40 LIGAND; CHOLESTEROL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; SIMVASTATIN;

EID: 4344663742     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Ferroni P, Basili S, Vieri M, et al. Soluble P-selectin and proinflammatory cytokines in patients with polygenic type II a Hypercholesterolaemia. Haemostasis 1999;9:277-285.
2. Phipps RP. Atherosclerosis: the emerging role of inflammation and the CD40-CD40L system. Proc Natl Acad Sci U S A 2000;97:6930-6932.
3. Schonbeck U, Sukhova GK, Schonbeck U, et al. Inhibition of CD40 signaling limits evolution established atherosclerosis in mice. Proc Natl Acad Sci U S A 2000;97:7458-7463.
4. Michelson AD, Barnard MR, Krueger LA, et al. Evaluation of platelet function by flow cytometry. Methods 2000;21:259-270.
5. Aukrust P, Muller F, Ueland BS, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Circulation 1999;100:614-620.
6. Garlichs CD, John S, Schmeiber A, et al. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolaemia. Circulation 2001;104:2395-2400.
7. Yan JC, Wu ZG, Chen JM, et al. The clinical implications of increased expression of CD40L in patients with acute coronary syndromes. Chin Med J 2002;115:491-493.